JamesAlexanderMcKinnellMD
Infectious Disease • Torrance, CAAssistant Professor, Medicine, University of California Los Angeles David Geffen SOM
Dr. McKinnell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 W Carson St FL 2
Division of ID 2ND floor RB2
Torrance, CA 90502Phone+1 310-222-3814Fax+1 310-326-5679
Education & Training
University of Alabama Medical CenterFellowship, Infectious Disease, 2007 - 2009
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2004 - 2007
Columbia University Vagelos College of Physicians and SurgeonsClass of 2004
Certifications & Licensure
CA State Medical License 2006 - 2026
AL State Medical License 2007 - 2009- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance Start of enrollment: 2011 Jan 01
- Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections Start of enrollment: 2014 May 01
- A Study of Baricitinib (LY3009104) in Participants With COVID-19 Start of enrollment: 2020 Jun 12
Publications & Presentations
PubMed
- 3 citationsReducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes.Gabrielle M Gussin, James A McKinnell, Raveena D Singh, Loren G Miller, Ken Kleinman
JAMA. 2024-05-14 - 5 citationsChlorhexidine and Mupirocin for Clearance of Methicillin-Resistant Staphylococcus aureus Colonization After Hospital Discharge: A Secondary Analysis of the Changing Li...Loren G Miller, Raveena Singh, Samantha J Eells, Daniel Gillen, James A McKinnell
Clinical Infectious Diseases. 2023-02-08 - Post-discharge decolonization of patients harboring methicillin-resistant(MRSA) USA300 strains: secondary analysis of the CLEAR Trial.Gabrielle M Gussin, Lauren Heim, Thomas Tjoa, James A McKinnell, Loren G Miller
Infection Control and Hospital Epidemiology. 2023-02-01
Press Mentions
Remember Overwhelmed Hospitals Across the US Three Years Ago?January 28th, 2021
Plazomicin Noninferior to Meropenem for Complicated UTIFebruary 21st, 2019
Plazomicin for Tough Infections: A Tale of 2 Clinical TrialsFebruary 21st, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
